Literature DB >> 23117274

Indomethacin prevents post-ERCP pancreatitis in selected high-risk patients.

Mattia Bonzi1, Elisa Maria Fiorelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117274     DOI: 10.1007/s11739-012-0872-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  8 in total

1.  Post-ERCP pancreatitis: new momentum.

Authors:  T Rabenstein; E G Hahn
Journal:  Endoscopy       Date:  2002-04       Impact factor: 10.093

Review 2.  Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.

Authors:  Dirk Bassler; Matthias Briel; Victor M Montori; Melanie Lane; Paul Glasziou; Qi Zhou; Diane Heels-Ansdell; Stephen D Walter; Gordon H Guyatt; David N Flynn; Mohamed B Elamin; Mohammad Hassan Murad; Nisrin O Abu Elnour; Julianna F Lampropulos; Amit Sood; Rebecca J Mullan; Patricia J Erwin; Clare R Bankhead; Rafael Perera; Carolina Ruiz Culebro; John J You; Sohail M Mulla; Jagdeep Kaur; Kara A Nerenberg; Holger Schünemann; Deborah J Cook; Kristina Lutz; Christine M Ribic; Noah Vale; German Malaga; Elie A Akl; Ignacio Ferreira-Gonzalez; Pablo Alonso-Coello; Gerard Urrutia; Regina Kunz; Heiner C Bucher; Alain J Nordmann; Heike Raatz; Suzana Alves da Silva; Fabio Tuche; Brigitte Strahm; Benjamin Djulbegovic; Neill K J Adhikari; Edward J Mills; Femida Gwadry-Sridhar; Haresh Kirpalani; Heloisa P Soares; Paul J Karanicolas; Karen E A Burns; Per Olav Vandvik; Fernando Coto-Yglesias; Pedro Paulo M Chrispim; Tim Ramsay
Journal:  JAMA       Date:  2010-03-24       Impact factor: 56.272

Review 3.  A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.

Authors:  B J Elmunzer; A K Waljee; G H Elta; J R Taylor; S M A Fehmi; P D R Higgins
Journal:  Gut       Date:  2008-03-28       Impact factor: 23.059

4.  Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis.

Authors:  Fumio Omata; Gautam Deshpande; Yasuharu Tokuda; Osamu Takahashi; Sachiko Ohde; David L Carr-Locke; Joshua L Jacobs; Tetsuya Mine; Tsuguya Fukui
Journal:  J Gastroenterol       Date:  2010-04-07       Impact factor: 7.527

5.  Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.

Authors:  M L Freeman; J A DiSario; D B Nelson; M B Fennerty; J G Lee; D J Bjorkman; C S Overby; J Aas; M E Ryan; G S Bochna; M J Shaw; H W Snady; R V Erickson; J P Moore; J P Roel
Journal:  Gastrointest Endosc       Date:  2001-10       Impact factor: 9.427

6.  Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.

Authors:  Angelo Andriulli; Gioacchino Leandro; Telemaco Federici; Antonio Ippolito; Rosario Forlano; Angelo Iacobellis; Vito Annese
Journal:  Gastrointest Endosc       Date:  2007-04       Impact factor: 9.427

7.  Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis.

Authors:  Hui-Fen Dai; Xiao-Wen Wang; Kui Zhao
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2009-02

8.  Risk factors for complications after performance of ERCP.

Authors:  Jo Vandervoort; Roy M Soetikno; Tony C K Tham; Richard C K Wong; Angelo P Ferrari; Henry Montes; Alfred D Roston; Adam Slivka; David R Lichtenstein; Frederick W Ruymann; Jacques Van Dam; Mike Hughes; David L Carr-Locke
Journal:  Gastrointest Endosc       Date:  2002-11       Impact factor: 9.427

  8 in total
  1 in total

Review 1.  Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis.

Authors:  Lei-Min Yu; Ke-Jia Zhao; Bin Lu
Journal:  Gastroenterol Res Pract       Date:  2018-02-08       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.